Publication: Flagging Drugs That Inhibit the Bile Salt Export Pump
Flagging Drugs That Inhibit the Bile Salt Export Pump
Date
Date
Date
| cris.lastimport.scopus | 2025-08-09T03:30:12Z | |
| cris.lastimport.wos | 2025-08-14T01:30:35Z | |
| dc.contributor.institution | University of Zurich | |
| dc.date.accessioned | 2016-01-18T15:15:59Z | |
| dc.date.available | 2016-01-18T15:15:59Z | |
| dc.date.issued | 2016-01-04 | |
| dc.description.abstract | The bile salt export pump (BSEP) is an ABC-transporter expressed at the canalicular membrane of hepatocytes. Its physiological role is to expel bile salts into the canaliculi from where they drain into the bile duct. Inhibition of this transporter may lead to intrahepatic cholestasis. Predictive computational models of BSEP inhibition may allow for fast identification of potentially harmful compounds in large databases. This article presents a predictive in silico model based on physicochemical descriptors that is able to flag compounds as potential BSEP inhibitors. This model was built using a training set of 670 compounds with available BSEP inhibition potencies. It successfully predicted BSEP inhibition for two independent test sets and was in a further step used for a virtual screening experiment. After in vitro testing of selected candidates, a marketed drug, bromocriptin, was identified for the first time as BSEP inhibitor. This demonstrates the usefulness of the model to identify new BSEP inhibitors and therefore potential cholestasis perpetrators. | |
| dc.identifier.doi | 10.1021/acs.molpharmaceut.5b00594 | |
| dc.identifier.issn | 1543-8384 | |
| dc.identifier.scopus | 2-s2.0-84953450023 | |
| dc.identifier.uri | https://www.zora.uzh.ch/handle/20.500.14742/115428 | |
| dc.identifier.wos | 000367866200017 | |
| dc.language.iso | eng | |
| dc.subject.ddc | 610 Medicine & health | |
| dc.title | Flagging Drugs That Inhibit the Bile Salt Export Pump | |
| dc.type | article | |
| dcterms.accessRights | info:eu-repo/semantics/openAccess | |
| dcterms.bibliographicCitation.journaltitle | Molecular Pharmaceutics | |
| dcterms.bibliographicCitation.number | 1 | |
| dcterms.bibliographicCitation.originalpublishername | American Chemical Society (ACS) | |
| dcterms.bibliographicCitation.pageend | 171 | |
| dcterms.bibliographicCitation.pagestart | 163 | |
| dcterms.bibliographicCitation.pmid | 26642869 | |
| dcterms.bibliographicCitation.volume | 13 | |
| dspace.entity.type | Publication | en |
| uzh.contributor.affiliation | Universitat Wien | |
| uzh.contributor.affiliation | Universitat Wien | |
| uzh.contributor.affiliation | Medizinische Universitat Wien | |
| uzh.contributor.affiliation | Universitat Wien | |
| uzh.contributor.affiliation | Medizinische Universitat Wien | |
| uzh.contributor.affiliation | AstraZeneca Sweden | |
| uzh.contributor.affiliation | AstraZeneca Sweden | |
| uzh.contributor.affiliation | Medizinische Universitat Wien | |
| uzh.contributor.affiliation | UniversitätsSpital Bern | |
| uzh.contributor.affiliation | Medizinische Universitat Wien | |
| uzh.contributor.affiliation | Universitat Wien | |
| uzh.contributor.author | Montanari, Floriane | |
| uzh.contributor.author | Pinto, Marta | |
| uzh.contributor.author | Khunweeraphong, Narakorn | |
| uzh.contributor.author | Wlcek, Katrin | |
| uzh.contributor.author | Sohail, M Imran | |
| uzh.contributor.author | Noeske, Tobias | |
| uzh.contributor.author | Boyer, Scott | |
| uzh.contributor.author | Chiba, Peter | |
| uzh.contributor.author | Stieger, Bruno | |
| uzh.contributor.author | Kuchler, Karl | |
| uzh.contributor.author | Ecker, Gerhard F | |
| uzh.contributor.correspondence | No | |
| uzh.contributor.correspondence | No | |
| uzh.contributor.correspondence | No | |
| uzh.contributor.correspondence | No | |
| uzh.contributor.correspondence | No | |
| uzh.contributor.correspondence | No | |
| uzh.contributor.correspondence | No | |
| uzh.contributor.correspondence | No | |
| uzh.contributor.correspondence | No | |
| uzh.contributor.correspondence | No | |
| uzh.contributor.correspondence | Yes | |
| uzh.document.availability | postprint | |
| uzh.eprint.datestamp | 2016-01-18 15:15:59 | |
| uzh.eprint.lastmod | 2025-08-14 01:36:44 | |
| uzh.eprint.statusChange | 2016-01-18 15:15:59 | |
| uzh.funder.name | FP7 | |
| uzh.funder.name | FP7 | |
| uzh.funder.projectNumber | 115002 | |
| uzh.funder.projectNumber | 115002 | |
| uzh.funder.projectTitle | ETOX - Integrating bioinformatics and chemoinformatics approaches for the development of expert systems allowing the in silico prediction of toxicities | |
| uzh.funder.projectTitle | ETOX - Integrating bioinformatics and chemoinformatics approaches for the development of expert systems allowing the in silico prediction of toxicities | |
| uzh.harvester.eth | Yes | |
| uzh.harvester.nb | No | |
| uzh.identifier.doi | 10.5167/uzh-118806 | |
| uzh.jdb.eprintsId | 15466 | |
| uzh.oastatus.unpaywall | green | |
| uzh.oastatus.zora | Green | |
| uzh.publication.citation | Montanari, Floriane; Pinto, Marta; Khunweeraphong, Narakorn; Wlcek, Katrin; Sohail, M Imran; Noeske, Tobias; Boyer, Scott; Chiba, Peter; Stieger, Bruno; Kuchler, Karl; Ecker, Gerhard F (2016). Flagging Drugs That Inhibit the Bile Salt Export Pump. Molecular Pharmaceutics, 13(1):163-171. | |
| uzh.publication.originalwork | original | |
| uzh.publication.publishedStatus | final | |
| uzh.scopus.impact | 29 | |
| uzh.scopus.subjects | Molecular Medicine | |
| uzh.scopus.subjects | Pharmaceutical Science | |
| uzh.scopus.subjects | Drug Discovery | |
| uzh.workflow.doaj | uzh.workflow.doaj.false | |
| uzh.workflow.eprintid | 118806 | |
| uzh.workflow.fulltextStatus | public | |
| uzh.workflow.revisions | 53 | |
| uzh.workflow.rightsCheck | keininfo | |
| uzh.workflow.status | archive | |
| uzh.wos.impact | 26 | |
| Files | ||
| Publication available in collections: |